These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 12602124)
1. Congress has its brain on drug benefits. Birnbaum JH Fortune; 2003 Jan; 147(1):178. PubMed ID: 12602124 [No Abstract] [Full Text] [Related]
2. The need for health care reform. Mossinghoff GJ Health Syst Rev; 1994; 27(3):5-6. PubMed ID: 10134516 [No Abstract] [Full Text] [Related]
3. The placebo effect. Congress hopes you won't notice its prescription-drug plans are meant to help candidates, not patients. Tumulty K Time; 2002 Aug; 160(7):26. PubMed ID: 12195650 [No Abstract] [Full Text] [Related]
4. Prescription-drug prices. Frank RG N Engl J Med; 2004 Sep; 351(14):1375-7. PubMed ID: 15459294 [No Abstract] [Full Text] [Related]
5. Senate GOP tosses drug bill. Law would have let Medicare negotiate costs directly. DoBias M Mod Healthc; 2007 Apr; 37(17):12. PubMed ID: 17479495 [No Abstract] [Full Text] [Related]
6. Riding high on a drug bill. Harrington A Fortune; 2003 Sep; 148(4):168. PubMed ID: 12964298 [No Abstract] [Full Text] [Related]
8. Crossing boundaries. Big Pharma stalls discounted Maine Rx drug program. White C Revolution (Oakl); 2002; 3(6):9. PubMed ID: 12599702 [No Abstract] [Full Text] [Related]
9. Pharmaceuticals issue brief: pharmaceutical assistance programs: year end report--2004. Seay M Issue Brief Health Policy Track Serv; 2004 Dec; ():1-26. PubMed ID: 15724309 [No Abstract] [Full Text] [Related]
10. Terms of coverage for elderly top priority for drug industry. Interview by Patrick Mullen. Holmer AF Manag Care; 2001 Apr; 10(4):25-8, 30, 32 passim. PubMed ID: 11347497 [No Abstract] [Full Text] [Related]
11. Medicare should bargain for lower drug prices, study says. Med Health; 2005 Oct; 59(36):1, 3, 7. PubMed ID: 16240494 [No Abstract] [Full Text] [Related]
12. Prescription drug pricing: the consumer perspective. Searing A N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625 [No Abstract] [Full Text] [Related]
13. Medicare and the politics of prescription drug pricing. Oberlander J N C Med J; 2003; 64(6):303-4. PubMed ID: 14983626 [No Abstract] [Full Text] [Related]
14. The role of the state as a drug purchaser. Palumbo FB Food Drug Law J; 2001; 56(3):267-80. PubMed ID: 11944639 [No Abstract] [Full Text] [Related]
15. PBMs get new role. Seen as key to drug cost control under new benefit. Becker C Mod Healthc; 2003 Dec 22-29; 33(51):31, 33. PubMed ID: 14723089 [No Abstract] [Full Text] [Related]
16. Misleading congress about drug development: Reply. Dimasi JA; Hansen RW; Grabowski HG J Health Polit Policy Law; 2008 Apr; 33(2):319-24; discussion 325-7. PubMed ID: 18325904 [TBL] [Abstract][Full Text] [Related]
17. Lilly purchase of PCS awaits FTC clearance. Scott L Mod Healthc; 1994 Oct; 24(44):29. PubMed ID: 10138146 [No Abstract] [Full Text] [Related]
18. Lilly deal's timing drew FTC notice. Scott L Mod Healthc; 1994 Oct; 24(43):8. PubMed ID: 10138136 [No Abstract] [Full Text] [Related]
19. Why drugs cost so much. Noonan D Newsweek; 2000 Sep; 136(13):22-30. PubMed ID: 11183315 [No Abstract] [Full Text] [Related]
20. Australia-United States Free Trade Agreement and the Australian Pharmaceutical Benefits Scheme. Sainsbury P Yale J Health Policy Law Ethics; 2004; 4(2):387-99. PubMed ID: 15536920 [No Abstract] [Full Text] [Related] [Next] [New Search]